DRCR.net Protocol T: Anti-VEGF Comparative Effectiveness Trial for DME
Dr. Neil Bressler discusses a post hoc analysis of DRCR.net’s Protocol T, a 2-year comparative efficacy randomized clinical trial of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME). The original Protocol T study showed that 2-year vision gains were comparable between all 3 drugs for center-involved DME. This post hoc analysis showed that for eyes…